June 10, 2024

Dr. Feldman Named 2024 WIELD Trailblazer

Women Inspiring and Elevating Leadership in Diabetes (WEILD) named Eva Feldman, M.D., Ph.D., as a woman shaping diabetes and metabolism research and care.

From WIELD's website:

The WIELD Advisory Board and “Elevate working group” of WIELD are proud to announce the list of Diabetes Trailblazers for 2024. These are women that have nominated by their peers and that have had a critical impact on research and/or care in the fields of diabetes, obesity, and metabolism. 

portrait of Dr. Eva Feldman

Eva Feldman, MD

James W. Albers Distinguished University Professor of Neurology
Russel N. DeJong Professor of Neurology
Director, ALS Center of Excellence at Michigan Medicine
Director, NeuroNetwork for Emerging Therapies
University of Michigan

Website: https://medicine.umich.edu/dept/mneuronet/about/eva-l-feldman-md-phd
Twitter (X): @EvaFeldmanMDPhD

Expertise: Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease and has made numerous contributions to biomedical research and clinical care in many critical areas. Her primary focus has been on amyotrophic lateral sclerosis (ALS), brain health, and the neurologic complications of diabetes and obesity. She also has conducted pioneering research on developing stem cell therapies to treat these diseases.

Click here to see the other WIELD Trailblazers